137 completed. 137 Phase 2, 34 Phase 3, 24 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 137 | Completed 137 |
| Phase 3 | 34 | Completed 34 |
| Phase 1 | 24 | Completed 24 |
Follow Control: new trials by email Literature Review of Control trials Research Report on Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nurse-Led Elderly Sleep Intervention Otago programme, Otago programme + Cognifit, Control - Sleep, Gerontology | Phase 1 / Phase 2 | Completed | University of Castilla-La Mancha | 66 | 2025-09-01 | 2026-05-22 |
| A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality JUVÉDERM® VOLITE™, Control - Skin Quality Deficit | Phase 2 / Phase 3 | Completed | AbbVie | 135 | 2024-07-18 | 2026-02-18 |
| Effects of Platelet-Rich Fibrin on Postoperative Outcomes Following Nasosinusal Surgery Platelet-rich fibrin (PRF), Control - Turbinate Surgery | Phase 1 / Phase 2 | Completed | Hospital Edmundo Vasconcelos | 14 | 2024-06-15 | 2026-06-12 |
| Efficacy of Inhaled Methoxyflurane (Penthrox) as Adjunct for Urologic Procedures Under Local Anesthetic: A Pilot Study Methoxyflurane, Control - Scrotum Disease, Hydrocele Male | Phase 2 | Completed | University of Manitoba | 40 | 2024-04-17 | 2025-09-25 |
| A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years VLA1553 full dose, VLA1553 half dose, Control - Chikungunya Virus Infection | Phase 2 | Completed | Valneva Austria GmbH | 304 | 2023-12-18 | 2026-08-13 |
| Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment Dasatinib 70 mg, Placebo - HIV Infection Primary | Phase 2 | Completed | Fundació Institut Germans Trias i Pujol | 60 | 2023-10-16 | 2025-09-22 |
| Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201) PF614, Placebo - Acute Pain | Phase 2 | Completed | Ensysce Biosciences | 16 | 2023-10-05 | 2024-10-08 |
| Low Dose Versus High Dose Methylene Blue in Septic Patients Normal saline, Methylene Blue low dose, Methylene Blue high dose - Septic Shock | Phase 2 / Phase 3 | Completed | National Cancer Institute, Egypt | 90 | 2023-08-01 | 2024-07-05 |
| Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs) PASC transplantation (25 million PASCs/patient), Control - Parkinson Disease | Phase 1 / Phase 2 | Completed | ClusterXStem-Costa Rica | 40 | 2023-06-23 | 2026-10-22 |
| Montmorency Cherry Supplementation, Sleep, and Inflammation Montmorency cherry supplement, Control - Insomnia Chronic, Inflammation | Phase 1 / Phase 2 | Completed | Michigan State University | 34 | 2023-02-18 | 2025-09-08 |
| Add-on Reparixin in Adult Patients With ARDS Reparixin 600mg, Matching Placebo - Acute Respiratory Distress Syndrome, Adult | Phase 2 | Completed | Dompé Farmaceutici S.p.A | 66 | 2022-12-06 | 2026-05-11 |
| Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer xintilimab injection, Control - Neoadjuvant Chemoradiation Therapy, Rectal Cancer | Phase 2 / Phase 3 | Completed | Changhai Hospital | 201 | 2022-10-01 | 2026-01-02 |
| the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy N-acetyl cysteine, Placebo, NAc - Drug Resistant Epilepsy | Phase 2 | Completed | Tanta University | 90 | 2022-09-15 | 2025-07-01 |
| Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance. UC-MSCs, Secretomes, UC-MSCs and Secretomes - Polycystic Ovary Syndrome | Phase 1 / Phase 2 | Completed | PT. Prodia Stem Cell Indonesia | 44 | 2022-09-01 | 2026-02-25 |
| A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy GSK3228836, GSK3528869A, Control - Hepatitis B, Chronic | Phase 2 | Completed | GlaxoSmithKline | 174 | 2022-03-22 | 2025-12-30 |
| Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol 6% Bemotrizinol (BEMT) in a basic sunscreen oil formulation, 6% Bemotrizinol (BEMT) dispersion in petrolatum, Sunscreen oil vehicle with 10% ethanol as penetration enhancer without BEMT - Sunburn | Phase 2 | Completed | dsm-firmenich Switzerland AG | 224 | 2022-02-23 | 2022-08-26 |
| Targeting ATR in Soft-tissue Sarcomas Association of berzosertib with gemcitabine, Gemcitabine - Leiomyosarcoma, Adult | Phase 2 | Completed | Institut Bergonié | 58 | 2022-02-09 | 2026-05-05 |
| Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression Metformin, Empagliflozin, Control - Renal Insufficiency, Chronic | Phase 2 / Phase 3 | Completed | Tanta University | 118 | 2022-01-01 | 2025-08-14 |
| Methylene Blue for the Prevention of Hypotension During Hemodialysis Methylene Blue, Control - Acute Kidney Injury, Shock | Phase 2 | Completed | Federal University of São Paulo | 261 | 2021-10-21 | 2026-04-17 |
| Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury. NMES, Vitamin D, Passive movement - Spinal Cord Injury | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 6 | 2021-10-01 | 2026-01-23 |
Showing 20 of 137. Sign in to see all of them.
COVID-19 (6) · Diabetes Mellitus, Type 2 (5) · Diabetes Mellitus (4) · Inflammation (4) · Motor Activity (4) · Myocardial Infarction (4) · Pain, Postoperative (4) · Spinal Cord Injuries (4) · Alzheimer Disease (3) · Cystic Fibrosis (3) · Heart Failure (3) · Peripheral Arterial Disease (3) · Pneumonia (3) · Pre-Eclampsia (3) · Acute Kidney Injury (2)
Royan Institute (5) · Johns Hopkins University (3) · Assiut University (2) · Dompé Farmaceutici S.p.A (2) · Islamic Azad University, Sanandaj (2) · Mesoblast, Ltd. (2) · National Cancer Institute, Egypt (2) · Tanta University (2) · The Cleveland Clinic (2) · Universidad de Granada (2) · University of Pittsburgh (2) · University of Sao Paulo (2) · VA Office of Research and Development (2) · AbbVie (1) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)
United States (52) · Canada (10) · Spain (10) · Egypt (8) · Brazil (7) · Germany (7) · United Kingdom (7) · France (6) · Iran (6) · China (5) · Italy (5) · Mexico (4) · Czechia (3) · Austria (2) · Belgium (2)
Ashraf Moini, MD (2) · Ehab H Shaker, MD (2) · Hamid Gourabi, PhD (2) · Hossein Baharvand, PhD (2) · Julio J Ochoa, Ph.D. (2) · Marzieh Shiva, MD (2) · Paul C Cremer, M. D. (2) · Roger Brown (2) · Santiago A Garcia, MD (2) · A Bhansali (1) · Adriana Andrade, MD, MPH (1) · Aisha K Yousafzai, PhD (1)
PMID 33754144, PMID 10439740, PMID 10686270, PMID 11032280, PMID 11425500, PMID 11595691, PMID 11772567, PMID 12088953, PMID 12960545, PMID 15125017, PMID 15781453, PMID 15863172, PMID 16174242, PMID 16473126, PMID 16616662, PMID 16901646, PMID 17297830, PMID 1742815, PMID 17655918, PMID 18385498, PMID 18407790, PMID 18801868, PMID 19128879, PMID 19422355, PMID 19559969, PMID 19618698, PMID 19640281, PMID 19794023, PMID 19944358, PMID 19944914, PMID 20418657, PMID 20495811, PMID 20556751, PMID 21410418, PMID 21452051, PMID 21530398, PMID 21806579, PMID 21907959, PMID 22103808, PMID 22116817, PMID 22221277, PMID 22231013, PMID 22352784, PMID 22505632, PMID 22563751, PMID 22742517, PMID 22776413, PMID 22891807, PMID 22914404, PMID 23034965
2009 (3), 2018 (2), 5KL2TR001109-05 (1), K07CA132916 (1), P01HL103455 (1), R00NR016484 (1), R01CA134903 (1), R01DA012403 (1), R01DA013496 (1), R01DA023877 (1), R01HL042814 (1), R01MH066684 (1), R01NR007652 (1), R01NS052448 (1), R21AT004493 (1)